Zydus Lifesciences US arm bags USFDA nod for Brivaracetam Tablets to treat partial-onset seizures Ruchika Sharma6 Oct 2022 11:17 AM ISTBrivaracetam is indicated for the treatment of partial-onset seizures in patients 4 years of age and older.
Zydus Lifesciences US arm bags USFDA nod for generic version of Mirabegron ER tablets Ruchika Sharma3 Oct 2022 12:15 PM ISTMirabegron is indicated for the treatment of overactive bladder (OAB) with symptoms of urinary incontinence, urgency, and urinary frequency.
USFDA issues 2 observations for Zydus Lifesciences arm Ahmedabad facility Ruchika Sharma1 Oct 2022 2:30 PM ISTAhmedabad: Pharma major, Zydus Lifesciences, has recently announced that the US Food and Drug Administration (USFDA) has concluded a Pre-Approval...
Zydus Lifesciences bags USFDA nod for Sildenafil for Oral Suspension Ruchika Sharma1 Oct 2022 12:10 PM ISTThe drug will be manufactured at the group’s formulation manufacturing facility at Baddi, Himachal Pradesh, India.
Zydus Lifesciences launches cancer drug Lenalidomide in US Ruchika Sharma20 Sept 2022 4:00 PM ISTAhmedabad: Drugmaker, Zydus Lifesciences Limited (formerly known as Cadila Healthcare Limited), has recently announced that the company has...
Zydus Lifesciences US arm secures USFDA nod for Sugammadex Injection Ruchika Sharma16 Sept 2022 1:30 PM ISTThe drug will be manufactured at the group’s injectables manufacturing facility at Jarod, India.
Zydus Lifesciences US arm bags USFDA nod for schizophrenia drug Cariprazine Ruchika Sharma13 Sept 2022 11:01 AM ISTCariprazine is an atypical antipsychotic indicated for the treatment of schizophrenia and acute treatment of manic or mixed episodes associated with...
Zydus Lifesciences in-licenses critical drug MonoFerric for CKD patients from Pharmacosmos A/S of Denmark Ruchika Sharma9 Sept 2022 2:34 PM ISTMonoFerric is indicated for the treatment of iron deficiency in adult patients when oral iron preparations are ineffective or cannot be used or where...
Lupin, Zydus Lifesciences recall products in US over manufacturing issues Ruchika Sharma3 Sept 2022 12:03 PM ISTNew Delhi: Home-grown drug makers Zydus Lifesciences and Lupin are recalling products in the US, the world's largest market for medicines, due to...
Zydus bags USFDA nod for Venlafaxine ER Tablets, Pregabalin ER Tablets Ruchika Sharma1 Sept 2022 11:00 AM ISTAhmedabad: Drugmaker, Zydus Lifesciences Limited (formerly known as Cadila Healthcare Limited), has recently announced that the company has received...
Zydus Lifecsciences begins Desidustat Phase IV trial in patients with CKD induced anemia Ruchika Sharma31 Aug 2022 12:30 PM ISTDesidustat is currently approved in India as Oxemia for the treatment of anemia in Chronic Kidney Disease (CKD) patients.
Zydus Lifesciences consolidated net profit falls to Rs 518 crore in Q1 Ruchika Sharma13 Aug 2022 9:00 AM ISTNew Delhi: Zydus Lifesciences on Wednesday reported a 13 percent decline in consolidated net profit at Rs 518 crore for the first quarter ended June...
